Strategies to Overcome Biological Barriers Associated with Pulmonary Drug Delivery by Adam J. Plaunt, Tam L. Nguyen, Michel R. Corboz, Vladimir S. Malinin, David C. Cipolla

Get full text

Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, mitigates interferon-α-accelerated lupus nephritis in mice by Kuan-Ju Chen, Jimin Zhang, Daniel LaSala, Jessica Basso, Donald Chun, Yuchen Zhou, Patrick P. McDonald, Walter R. Perkins, David C. Cipolla

Get full text

Brensocatib (an oral, reversible inhibitor of dipeptidyl peptidase-1) attenuates disease progression in two animal models of rheumatoid arthritis by Patrick P. McDonald, Franziska Graf Leifer, Jessica Basso, Dan Lasala, Dedong Li, Kuan-Ju Chen, Jimin Zhang, Walter R. Perkins, David C. Cipolla

Get full text

The pharmacokinetic profile of brensocatib and its effect on pharmacodynamic biomarkers including NE, PR3, and CatG in various rodent species by Jessica Basso, Kuan-Ju Chen, Yuchen Zhou, Lilly Mark, Daniel LaSala, Arielle Dorfman, Mary Atalla, Donald Chun, Veronica Viramontes, Christina Chang, Franziska Leifer, Patrick P. McDonald, David C. Cipolla

Get full text

Pharmacologic inhibition of dipeptidyl peptidase 1 (cathepsin C) does not block in vitro granzyme-mediated target cell killing by CD8 T or NK cells by Vivien R. Sutton, Vivien R. Sutton, Sally V. Watt, Sally V. Watt, Hedieh Akhlaghi, Hedieh Akhlaghi, David C. Cipolla, Kuan-Ju Chen, Daniel LaSala, Patrick P. McDonald, Paul A. Beavis, Paul A. Beavis, Isabelle Munoz, Isabelle Munoz, Adrian W. Hodel, Adrian W. Hodel, Tahereh Noori, Tahereh Noori, Ilia Voskoboinik, Ilia Voskoboinik, Joseph A. Trapani, Joseph A. Trapani

Get full text